|
|
||||||||
INFLAMMATION/IMMUNITY/MEDIATORS
L-Integrin I domain cyclic peptide antagonist selectively inhibits T cell adhesion to pancreatic islet microvascular endothelium
1Department of Pathology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana; and 2Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas
Submitted 22 June 2004 ; accepted in final form 14 August 2004
Insulitis is a hallmark feature of autoimmune diabetes that ultimately results in islet
-cell destruction. We examined integrin requirements and specific inhibition of integrin structure in T cell and monocyte adhesion to pancreatic islet endothelium. Examination of cell surface integrin expression on WEHI 7.1 T cells revealed prominent expression of
-,
1-,
L-integrins, and low expression of
M-integrins; whereas WEHI 274.1 monocytes showed significant staining for
2-,
1-,
M-molecules and no expression of
L-molecules. Unstimulated islet endothelium showed constitutive levels of ICAM-1 counter-ligand expression with minimal VCAM-1 expression; however, TNF-
stimulation increased cell surface density of both molecules. TNF-
increased T cell and monocyte rolling and adhesion under hydrodynamic flow conditions. Administration of a cyclic peptide competitor for the
L-integrin I domain binding sites (cyclo1,12-PenITDGEATDSGC) blocked T cell adhesion without inhibiting monocyte adhesion. Examination of T cell rolling revealed that cLAB.L treatment increased the average rolling velocity on activated endothelium and significantly decreased the fraction of T cells rolling at
50 µm/s, suggesting that cLAB.L treatment interferes with signal activation events required for the conversion of T cell rolling to firm adhesion. These data demonstrate for the first time that cyclic peptide antagonists against
L-integrin I domain attenuate T cell recruitment to islet endothelium.
lymphocyte function-associated antigen-1; leukocyte; pancreas; diabetes
This article has been cited by other articles:
![]() |
J. D. Glawe, D. R. Patrick, M. Huang, C. D. Sharp, S. C. Barlow, and C. G. Kevil Genetic Deficiency of Itgb2 or ItgaL Prevents Autoimmune Diabetes Through Distinctly Different Mechanisms in NOD/LtJ Mice Diabetes, June 1, 2009; 58(6): 1292 - 1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Sharp, M. Huang, J. Glawe, D. R. Patrick, S. Pardue, S. C. Barlow, and C. G. Kevil Stromal Cell Derived Factor-1/CXCL12 Stimulates Chemorepulsion of NOD/LtJ T-Cell Adhesion to Islet Microvascular Endothelium Diabetes, January 1, 2008; 57(1): 102 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goebel, M. Huang, W. C. Davis, M. Jennings, T. J. Siahaan, J. S. Alexander, and C. G. Kevil VEGF-A stimulation of leukocyte adhesion to colonic microvascular endothelium: implications for inflammatory bowel disease Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G648 - G654. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |